TVRD
NASDAQ · Pharmaceuticals
Tvardi Therapeutics Inc
$4.21
+0.00 (+0.00%)
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+804.3% upside
Low Target
$23.38
Average Target
$38.07
High Target
$43.34
Current Price
$4.21
Current
$4.21
$4.21
Target
$38.07
$38.07
$23.38
$38.07 avg
$43.34
Scenario Analysis
Bear Case
$23.38
455.3%
Low target
Base Case
$38.07
+804.3%
Avg target
Bull Case
$43.34
+929.5%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$43.65
-90.4% from high
52-Week Low
$2.75
+53.1% from low
Target vs 52W High
$38.07
-12.8% vs high
Next Earnings Report
May 19, 2026
8d
until earnings
EPS Est: $-0.76
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals